
Introduction
During the latest episode of Shark Tank India Season 4, sibling investors Shreyansh and Anousha Chauhan showed up with their business, Beautywise, whose mission is to transform the wellness and beauty business with scientifically founded supplements. But their pitch reignited a furor among the Sharks, as much as on the slimming solutions they introduced.
The Pitch: Beautywise’s Vision
Beautywise has a series of supplements focusing on skin, hair, and overall health. The promoters looked for an investment of ₹1 crore for 1.5% equity at a valuation of the company around ₹66.67 crore. They highlighted that they are scientifically backed products and their Skin Brilliance supplement, according to them, shows results in 30 days.
Sharks’ Reactions: A Mix of Interest and Concern
Though certain Sharks recognized the beauty potential of Beautywise’s products, reservations existed in the slimming supplements:
Namita Thapar raised major doubts over the slimming tablets, citing increasing usage of weight loss treatment misused socially during kitty parties. She raised concerns about such a product being used effectively, even when released for sale with very little clinical backing.
Vineeta Singh recognized the growing need for nutritional beauty products in India but expressed fears regarding the marketing tactics and the health impact of the slimming supplements.
Clinical Trials and Regulatory Scrutiny
The founders asserted that they had performed six clinical trials on 60 people, seeing an average weight loss of 1.4 kg and a decrease in waist circumference. But Namita Thapar pointed out the small sample size and that these trials were not carried out in India, questioning their relevance to the Indian population.
Investment Offers and Decisions
In spite of the issues, Beautywise had investment offers:
Ritesh Agarwal bid ₹1 crore for 2.38% equity, subject to independent confirmation of the clinical trials.
Kunal Bahl bid ₹2.5 crore for a 5% stake, showing full faith in the potential of the company.
Aman Gupta showed interest but wanted to invest individually, resulting in further negotiation.
The founders ended up accepting the offer of Kunal Bahl, valuing the company at ₹50 crore.
Public and Expert Opinions
The incident sparked debate among viewers and healthcare experts:
Health Practitioners warned against use of unproven slimming supplements, which highlighted the use of evidence-based therapies.
People who consume reported mixed responses where some were attracted to the product while others did not believe them to be working and safe.
Conclusion
Beautywise’s Shark Tank India Season 4 appearance brought to the fore the challenges of launching health-product-related offerings in a market more and more attuned to wellness trends. Although the firm achieved meaningful investment, the questions raised serve to emphasize the need for extensive clinical proof and ethical marketing principles in the supplement space.